Overall survival of Black patients with newly diagnosed multiple myeloma in the era of triplet and quadruplet therapies.

Hamlet Gasoyan, Shahzad Raza, Michael B Rothberg, Jeffrey D Kovach, Nicholas J Casacchia, Jason Valent, Faiz Anwer

Abstract readLetter

In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hamlet GasoyanCenter for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, OH, USA. gasoyah@ccf.org.ORCID http://orcid.org/0000-0002-1627-9777

Shahzad RazaCleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-2739-2265

Michael B RothbergCenter for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-2063-1876

Jeffrey D KovachDepartment of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Nicholas J CasacchiaCenter for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0003-2291-835X

Jason ValentCleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.

Faiz AnwerCleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.ORCID http://orcid.org/0000-0001-6914-7439

Funding

Modifiable Determinants of Disparities in Multiple Myeloma Treatment PatternsR00CA277136 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI Hamlet Gasoyan · 2024 to 2026

$747k

NCI NIH HHS R00 CA277136U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R00CA277136

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42844272

DOI10.1038/s41408-026-01645-1

PMCPMC13646269

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.